FindTrial
Sign In

Understanding Immunity to Measles, Mumps, and Rubella in South Indian Adults

Charting the Path to Elimination: Insights into Immune Responses to Measles, Mumps, and Rubella in an Adult South Indian Community Cohort - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099553
Enrollment
250
Registered
2025-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Stichting Blockchain for Impact Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 40 years, Residing in VHDSS zones 3 or 4, Providing informed consent

Exclusion criteria

Exclusion criteria: Immunosuppression for less than 6 months Chronic illness impacting immunity (e.g., HIV)

Design outcomes

Primary

MeasureTime frame
Evidence-based recommendations for targeted booster vaccination strategies. Data-driven support for India s measles and rubella elimination efforts. Data-driven support to include Mumps in the National Immunisation Programme. Timepoint: Eighteen months—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Ramya Madhavan

Christian Medical College

ramya.m@cmcvellore.ac.in9787724132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026